Mechanisms of gefitinib-induced interstitial pneumonitis: why and how the TKI perturbs innate immune systems?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)1321-1322
Number of pages2
JournalOncotarget
Volume12
Issue number13
DOIs
Publication statusPublished - 2021 Jun 22

Keywords

  • Gefitinib
  • Inflammation
  • Interstitial pneumonitis
  • NLRP3 inflammasome
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Oncology

Cite this